Globus Medical unveils new 'self-locking' spinal implant device

Globus Medical's Monument device is designed to aid in spondylolithesis reduction.--Courtesy of Globus Medical

Musculoskeletal device maker Globus Medical ($GMED) has added a new product to its line of spinal implants it claims will allow surgeons to be more efficient when operating on patients with spondylolisthesis.

Dubbed Monument, the device features a self-locking and threaded mechanical element that helps aid in spondylolisthesis reduction, which is the forward displacement of a vertebra that typically occurs after a break or fracture. This feature can be engaged to reduce the implant up to 8 mm when in place and the screws are designed for optimal cortical purchase, the company said.

"Our new system includes all the benefits typical of an anterior lumbar interbody spacer with a large stabilizing surface and large graft window to optimize fusion," Andrew Iott, senior vice president of product development, said in a statement.

Globus won FDA approval for Monument in December 2013.

Founded in 2003, the Audubon, PA-based company markets more than 100 products to treat spinal disorders, and brought in $114 million in sales in the first quarter of 2014 compared to $105 million for the same period last year. Globus, which went public in August 2012, estimates the world spine market at about $10 billion and says an aging population and growing number of spinal procedures will push that number higher.

- read the release

Suggested Articles

Medtronic has expanded its portfolio aimed at improving the safety of head and neck surgeries, with a new acquisition and an FDA clearance.

By casting a broad, digital net to pick up the signs of coronavirus outbreaks, researchers hope to build an early warning system from wearable tech.

C2N Diagnostics launched a blood test that can identify the state of amyloid plaque in the brain, one of the hallmarks of Alzheimer's disease.